Sheaff Brock Investment Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-9,748
Closed -$1.07M 539
2019
Q1
$1.07M Sell
9,748
-149
-2% -$15.6K 0.13% 126
2018
Q4
$910K Sell
9,897
-817
-8% -$82.7K 0.14% 132
2018
Q3
$1.18M Sell
10,714
-1,290
-11% -$134K 0.11% 126
2018
Q2
$1.12M Sell
12,004
-93
-0.8% -$8.01K 0.11% 134
2018
Q1
$1M Buy
12,097
+420
+4% +$37.3K 0.1% 145
2017
Q4
$1.06M Sell
11,677
-269
-2% -$22.4K 0.14% 143
2017
Q3
$910K Sell
11,946
-1,598
-12% -$121K 0.12% 165
2017
Q2
$1.02M Buy
+13,544
New +$939K 0.13% 149

Other funds holding PRAH

Sheaff Brock Investment Advisors's PRAH Position: Q2 2019 in Review

Sheaff Brock Investment Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2019, closing a stake of 9,748 shares — an estimated $1.07M sold.

Sheaff Brock Investment Advisors first reported a position in PRAH in Q2 2017 and held it in 8 quarters. The position peaked at $1.18M in Q3 2018. 329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

  • Sheaff Brock Investment Advisors reported no remaining PRA Health Sciences, Inc. position as of Q2 2019 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 9,748 PRA Health Sciences, Inc. shares in Q2 2019, an estimated $1.07M.
  • Sheaff Brock Investment Advisors first reported a position in PRA Health Sciences, Inc. in Q2 2017 and held it in 8 quarters.
  • Sheaff Brock Investment Advisors's PRA Health Sciences, Inc. position peaked at $1.18M in Q3 2018.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on Sheaff Brock Investment Advisors's 13F filing for Q2 2019, filed 31 Jul 2019.